Brady Wayne Wagner, MD | |
2211 Ne 139th St, Vancouver, WA 98686-2742 | |
(360) 487-1000 | |
Not Available |
Full Name | Brady Wayne Wagner |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 2211 Ne 139th St, Vancouver, Washington |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1649405671 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | MD60292835 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Brady Wayne Wagner, MD 12815 Sw Rita Dr, Beaverton, OR 97005-0720 Ph: (503) 806-0647 | Brady Wayne Wagner, MD 2211 Ne 139th St, Vancouver, WA 98686-2742 Ph: (360) 487-1000 |
News Archive
While therapeutic advances have improved survival of patients with follicular lymphoma (FL), it remains an incurable disease with inevitable relapse. This underscores the need for therapies and strategies to extend the duration of remission without significantly increasing toxicity and while maintaining quality of life.
Dyax Corp. (NASDAQ:DYAX) today announced a study published evaluating the Company's novel Patient Reported Outcome Measures (PROs) used to assess hereditary angioedema (HAE) attacks affirmed the PROs as valuable instruments in capturing HAE symptom severity and impact of treatment.
Specialty biopharmaceutical company Santarus, Inc. and biotech company Pharming Group NV today announced that they have reached agreement with the U.S. Food and Drug Administration (FDA) on the design of a Phase III clinical study with the investigational drug RHUCIN under the Special Protocol Assessment (SPA) process that is intended to support the submission of a Biologics License Application.
New analyses from the Women's Health Initiative (WHI) confirm that combination hormone therapy increases the risk of heart disease in healthy postmenopausal women. Researchers report a trend toward an increased risk of heart disease during the first two years of hormone therapy among women who began therapy within 10 years of menopause, and a more marked elevation of risk among women who began hormone therapy more than 10 years after menopause. Analyses indicate that overall a woman's risk of heart disease more than doubles within the first two years of taking combination HT.
› Verified 7 days ago
Dr. Andrew Douglass Zechnich, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3400 Main St, Vancouver, WA 98663 Phone: 360-696-5232 Fax: 360-696-5228 | |
Jeff S Brent, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 Ne 87th Ave, Vancouver, WA 98664 Phone: 360-882-2778 | |
Dr. Erin Meadows, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2211 Ne 139th St, Vancouver, WA 98686 Phone: 559-250-7564 | |
Megumi S Ketcham, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2211 Ne 139th St, Vancouver, WA 98686 Phone: 360-487-1000 | |
Dr. Jamie Mcginnity, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2211 Ne 139th St, Vancouver, WA 98686 Phone: 360-487-1000 | |
George T Lin, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2211 Ne 139th St, Vancouver, WA 98686 Phone: 360-487-1400 | |
Daniel M Bissell, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2211 Ne 139th St, Vancouver, WA 98686 Phone: 360-487-1400 |